Biocorrx Company Profile (OTCMKTS:BICX)

About Biocorrx

Biocorrx logoBioCorRx, Inc., formerly Fresh Start Private Management, Inc., is a holding company. The Company is an addiction healthcare solutions company operating in Santa Ana, California. The Company, through its subsidiary, Fresh Start Private, Inc., provides alcoholism and opioid treatment program. It offers a medication-assisted treatment program that combines non-addictive medication coupled with psycho-social counseling. It also distributes and licenses the BioCorRx Recovery Program for alcoholism and opioid addiction treatment. The BioCorRxO Recovery Program consists of over two parts, which include an implant, administered by a licensed physician, of a compounded formulation of the drug, Naltrexone (implanted under the skin) (the Implant), which reduces alcohol cravings over a period of time, and a structured, intensive one on one counseling program developed by it. It offers BioCorRx Recovery Program in over 10 locations, including California, Arizona, Atlanta, Illinois and others.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: OTCMKTS
  • Symbol: BICX
  • CUSIP:
Key Metrics:
  • Previous Close: $0.07
  • 50 Day Moving Average: $0.04
  • 200 Day Moving Average: $0.04
  • 52-Week Range: $0.01 - $0.10
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $11.20M
  • Outstanding Shares: 169,894,000
  • Beta: -0.56
Debt:
  • Debt-to-Equity Ratio: -0.07%
  • Current Ratio: 0.10%
  • Quick Ratio: 0.10%
Additional Links:
Companies Related to Biocorrx:

Analyst Ratings

Consensus Ratings for Biocorrx (OTCMKTS:BICX) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Biocorrx (OTCMKTS:BICX)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Biocorrx (OTCMKTS:BICX)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Biocorrx (OTCMKTS:BICX)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Biocorrx (OTCMKTS:BICX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Biocorrx (OTCMKTS:BICX)
Insider Ownership Percentage: 14.85%
Institutional Ownership Percentage: 0.01%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/27/2015Jorge Andrade JrDirectorSell125,000$0.06$7,500.00View SEC Filing  
2/26/2015Jorge Andrade JrDirectorSell245,000$0.05$12,250.00View SEC Filing  
2/23/2015Jorge Andrade JrDirectorSell215,000$0.06$12,900.00View SEC Filing  
2/17/2015Jorge Andrade JrDirectorSell90,000$0.08$7,200.00View SEC Filing  
2/10/2015Jorge Andrade JrDirectorSell60,000$0.09$5,400.00View SEC Filing  
10/28/2014Jorge Andrade JrDirectorSell25,000$0.09$2,250.00View SEC Filing  
10/13/2014Jorge Andrade JrDirectorSell80,000$0.09$7,200.00View SEC Filing  
10/7/2014Jorge Andrade JrDirectorSell40,000$0.11$4,400.00View SEC Filing  
10/1/2014Jorge Andrade JrDirectorSell30,000$0.13$3,900.00View SEC Filing  
9/29/2014Jorge Andrade JrDirectorSell170,000$0.10$17,000.00View SEC Filing  
9/22/2014Jorge Andrade JrDirectorSell130,000$0.10$13,000.00View SEC Filing  
9/15/2014Jorge Andrade JrDirectorSell90,000$0.10$9,000.00View SEC Filing  
9/8/2014Jorge Andrade JrDirectorSell95,000$0.11$10,450.00View SEC Filing  
8/22/2014Jorge Andrade JrDirectorSell100,000$0.13$13,000.00View SEC Filing  
8/14/2014Jorge Andrade JrDirectorSell300,000$0.14$42,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Biocorrx (OTCMKTS:BICX)
DateHeadline
finance.yahoo.com logoBioCorRx Provides Preclinical Study Update on BICX101 Development (OTCMKTS:BICX)
finance.yahoo.com - February 23 at 3:21 PM
finance.yahoo.com logoDrug Addiction Treatment Stocks to Watch (OTCMKTS:BICX)
finance.yahoo.com - February 22 at 3:56 PM
4-traders.com logoBiocorrx Inc : BioCorRx Announces the Appointment of Dr. Balbir S. Brar as VP of Drug Development (OTCMKTS:BICX)
www.4-traders.com - February 21 at 3:24 PM
finance.yahoo.com logoBioCorRx Announces the Appointment of Dr. Balbir S. Brar as VP of Drug Development (OTCMKTS:BICX)
finance.yahoo.com - February 21 at 10:41 AM
News IconThe Massachusetts ANGEL Program, Reducing Cost of Drug Addiction Treatment, Gets National Attention (OTCMKTS:BICX)
www.artipot.com - February 16 at 3:59 PM
4-traders.com logoRising Expenditure on R&D to Fuel the Growth of the Global Molecular Spectroscopy Market Through 2021: Technavio (OTCMKTS:BICX)
www.4-traders.com - February 13 at 9:27 PM
News IconBioCorRx (BICX) Update: FDA Results Imminent (OTCMKTS:BICX)
www.pr.com - February 13 at 9:27 PM
finance.yahoo.com logoANGEL Program Gets National Attention (OTCMKTS:BICX)
finance.yahoo.com - February 13 at 4:25 PM
finance.yahoo.com logoBioCorRx Provides Business Update Webcast (OTCMKTS:BICX)
finance.yahoo.com - February 10 at 3:23 PM
biz.yahoo.com logoBIOCORRX INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (OTCMKTS:BICX)
biz.yahoo.com - February 8 at 4:04 PM
finance.yahoo.com logoBioCorRx to Collaborate with the City of Anaheim to Treat Opioid and Alcohol Addiction (OTCMKTS:BICX)
finance.yahoo.com - February 8 at 4:04 PM
seekingalpha.com logo21st Century Cures Act Hopes To Reduce $41 Billion Annual Cost Of Opioid Treatments (OTCMKTS:BICX)
seekingalpha.com - January 22 at 3:53 PM
4-traders.com logoBiocorrx Inc : JGR Capital Partners Initiates Coverage on BioCorRx Inc. with a Price Target of $0.09 (OTCMKTS:BICX)
www.4-traders.com - January 21 at 3:02 AM
finance.yahoo.com logoJGR Capital Partners Initiates Coverage on BioCorRx Inc. with a Price Target of $0.09 (OTCMKTS:BICX)
finance.yahoo.com - January 19 at 8:24 PM
finance.yahoo.com logoBioCorRx Retains Innovative Science Solutions to Guide FDA Regulatory Process for its Naltrexone Products (OTCMKTS:BICX)
finance.yahoo.com - January 12 at 4:09 PM
finance.yahoo.com logoBioCorRx Inc. to Present at the 9th Annual LD Micro Main Event (OTCMKTS:BICX)
finance.yahoo.com - December 2 at 10:13 AM
4-traders.com logoBioCorRx Inc. (OTCMKTS:BICX) Files An 8-K Material Modification to Rights of Security Holders (OTCMKTS:BICX)
www.4-traders.com - November 30 at 11:13 AM
einnews.com logoBioCorRx Selects Covance for Non-Clinical Studies, Announces the Addition of Dr. Bal S. Brar to its Drug Development ... (OTCMKTS:BICX)
brazilbusiness.einnews.com - November 29 at 2:57 PM
finance.yahoo.com logoBioCorRx Selects Covance for Non-Clinical Studies, Announces the Addition of Dr. Bal S. Brar to its Drug Development Team, Plans Pre-IND Meeting with FDA (OTCMKTS:BICX)
finance.yahoo.com - November 29 at 2:57 PM
capitalcube.com logoBioCorRx, Inc. :BICX-US: Earnings Analysis: Q3, 2016 By the Numbers : November 18, 2016 (OTCMKTS:BICX)
www.capitalcube.com - November 18 at 12:26 PM
News Icon00 p.m. Eastern Time (OTCMKTS:BICX)
andhranews.net - October 6 at 9:21 AM
finance.yahoo.com logoBioCorRx Inc. to Host Corporate Update Webinar on Wednesday, October 12th at 2:00 p.m. Eastern Time (OTCMKTS:BICX)
finance.yahoo.com - October 6 at 9:21 AM
4-traders.com logoBioCorRx : to Present at the Singular Research 11th Annual Best of the Uncovereds Investment Conference September 22nd (OTCMKTS:BICX)
www.4-traders.com - September 21 at 8:23 AM
4-traders.com logoBioCorRx : Announces Update from First Joint Steering Committee Meeting for Injectable Naltrexone Product (OTCMKTS:BICX)
www.4-traders.com - September 15 at 8:46 PM
finance.yahoo.com logoBioCorRx Inc. Announces Update From First Joint Steering Committee Meeting for Injectable Naltrexone Product (OTCMKTS:BICX)
finance.yahoo.com - September 15 at 12:44 PM
finance.yahoo.com logoBioCorRx Inc. Announces BioCorRx Pharmaceuticals Subsidiary; Forms Joint Steering Committee for Injectable Naltrexone Technology (OTCMKTS:BICX)
finance.yahoo.com - August 31 at 3:49 PM
finance.yahoo.com logoBioCorRx, Inc. Announces Agreement With Dr. David Gastfriend to Provide Strategic Initiative and Corporate Development Consulting (OTCMKTS:BICX)
finance.yahoo.com - August 17 at 12:00 PM
News IconBioCorRx Announces License Agreement with TheraKine Ltd. to Develop New Injectable Naltrexone Technology (OTCMKTS:BICX)
www.releasewire.com - August 3 at 12:30 PM
biz.yahoo.com logoBIOCORRX INC. Files SEC form 8-K, Entry into a Material Definitive Agreement (OTCMKTS:BICX)
biz.yahoo.com - August 3 at 12:30 PM
finance.yahoo.com logoBioCorRx Retains MZ Group as Investor Relations Advisor (OTCMKTS:BICX)
finance.yahoo.com - July 20 at 10:28 AM
finance.yahoo.com logoBioCorRx Launches R&D Initiative to Pursue FDA Approval for Naltrexone Implant (OTCMKTS:BICX)
finance.yahoo.com - July 14 at 8:00 AM
finance.yahoo.com logoAlpine Creek and BioCorRx Announce Major Investment Into BioCorRx (OTCMKTS:BICX)
finance.yahoo.com - June 20 at 2:01 PM
biz.yahoo.com logoBIOCORRX INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statemen (OTCMKTS:BICX)
biz.yahoo.com - May 20 at 5:05 PM
biz.yahoo.com logoBIOCORRX INC. Files SEC form 8-K, Termination of a Material Definitive Agreement, Financial Statements and Exhibits (OTCMKTS:BICX)
biz.yahoo.com - April 18 at 4:13 PM
biz.yahoo.com logoBIOCORRX INC. Files SEC form 10-K, Annual Report (OTCMKTS:BICX)
biz.yahoo.com - April 14 at 2:55 PM
finance.yahoo.com logoBioCorRx's Program to Help Beat Alcohol and Opioid Addiction Now in 20 Locations and Growing in Time for Alcohol Awareness Month (OTCMKTS:BICX)
finance.yahoo.com - April 4 at 8:24 AM

Social

What is Biocorrx's stock symbol?

Biocorrx trades on the OTCMKTS under the ticker symbol "BICX."

How do I buy Biocorrx stock?

Shares of Biocorrx can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Biocorrx stock cost?

One share of Biocorrx stock can currently be purchased for approximately $0.07.

Biocorrx (OTCMKTS:BICX) Chart for Thursday, February, 23, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Biocorrx (OTCMKTS:BICX)

Earnings History Chart

Earnings by Quarter for Biocorrx (OTCMKTS:BICX)

Dividend History Chart

Dividend Payments by Quarter for Biocorrx (OTCMKTS:BICX)

Last Updated on 2/23/2017 by MarketBeat.com Staff